| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |